Colorcon Opens Major Facility in India - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Colorcon Opens Major Facility in India

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 5

Colorcon announced that it has completed a major expansion of its South Asia production facility in Verna, Goa, India. The Goa site operates under schedule M of the Indian FDA and IPEC guidelines, with Colorcon accredited to the latest ISO 9001 standard.

Colorcon provides film coatings, modified-release technologies, functional excipients and tablet-design services to the pharmaceutical industry. The Goa plant is one of six Colorcon manufacturing plants dedicated to film coatings. These plants are strategically located close to key customer centers in India, China, Europe, North America and Japan.

Subodh Priolkar, regional managing director for South Asia, said during the opening event that the investment would enable Colorcon to continue to meet the needs of its customers through security of supply and short lead times.

Martti Hedman, CEO of Colorcon, added that India is one of the fastest growing pharmaceutical markets and is also the most important production cluster of generic medicines for global markets. “Colorcon is investing heavily in India to support its customers during both development and manufacture,” Hedman said. “Speed to market, cost to produce and consistently high product quality are our customers’ strategic objectives.”

Source: Colorcon

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here